RCKT (Rocket Pharmaceuticals) OCF Yield %: -42.84 (As of Jul. 04, 2026)


RCKT Rocket Pharmaceuticals Inc RCKT
30 GF Score
Price $3.84
! 3 Warning Signs
View Full Analysis

What is Rocket Pharmaceuticals OCF Yield %?

Rocket Pharmaceuticals RCKT +9.25% 30 OCF Yield % is -42.84 as of Jul. 04, 2026. GuruFocus rates RCKT with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 1,414 Biotechnology companies, Rocket Pharmaceuticals ranks worse than 81.97% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Rocket Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-179.62 Mil, and Market Cap is $419.30 Mil. Therefore, Rocket Pharmaceuticals's OCF Yield % for today is -42.84%.

The historical rank and industry rank for Rocket Pharmaceuticals's OCF Yield % or its related term are showing as below:

RCKT' s OCF Yield % Range Over the Past 10 Years
Min: -42.84   Med: 0   Max: -42.84
Current: -42.84

During the past 13 years, the highest OCF Yield % of Rocket Pharmaceuticals was -42.84%. The lowest was -42.84%. And the median was %.

RCKT's OCF Yield % is ranked worse than
81.97% of 1414 companies
in the Biotechnology industry
Industry Median: -8.155 vs RCKT: -42.84

Rocket Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Rocket Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Rocket Pharmaceuticals OCF Yield % Related Terms

Rocket Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Rocket Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Pharmaceuticals OCF Yield % Chart

Rocket Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.60 -11.50 -7.20 -15.67 -49.98

Rocket Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.34 -74.10 -57.17 -36.65 -46.48

RCKT vs TENX, DMAC, AVIR: OCF Yield % Comparison

For the Biotechnology subindustry, Rocket Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rocket Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rocket Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Rocket Pharmaceuticals's OCF Yield % falls into.


RCKT
30GF Score
Rocket Pharmaceuticals Inc RCKT
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Rocket Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-190.014 / 380.2032
=-49.98%

Rocket Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-45.394 * 4 / 390.66392
=-46.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -42.84 mean?
Rocket Pharmaceuticals (RCKT) has a OCF Yield % of -42.84 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Rocket Pharmaceuticals and its competitors. According to the industry distribution chart, Rocket Pharmaceuticals ranks #1159 out of 1414 companies in the Biotechnology industry, placing it in the top 82%.
Is Rocket Pharmaceuticals' OCF Yield % too high?
Rocket Pharmaceuticals' current OCF Yield % is -42.84. Based on the distribution chart, Rocket Pharmaceuticals ranks #1159 out of 1414 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Rocket Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Pharmaceuticals' OCF Yield % compare to TENX and DMAC?
According to the Biotechnology industry distribution chart, Rocket Pharmaceuticals ranks #1159 out of 1414 companies for OCF Yield %. This places Rocket Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Rocket Pharmaceuticals and its competitors. Rocket Pharmaceuticals's current OCF Yield % is -42.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Pharmaceuticals stock overvalued right now?
Rocket Pharmaceuticals (RCKT) has a current OCF Yield % of -42.84. The current OCF Yield % is -42.84. Rocket Pharmaceuticals' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Rocket Pharmaceuticals (RCKT), the current OCF Yield % is -42.84 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Pharmaceuticals Business Description

Other Exchanges 9IP1:Germany
Address 9 Cedarbrook Drive, Cranbury, NJ, USA, 08512
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
30GF Score

Get the complete analysis for RCKT

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84
Price